Giant Cell Tumor of Tendon Sheath
- Author: James R Verheyden, MD; Chief Editor: Harris Gellman, MD more...
Giant cell tumors of the tendon sheath are the second most common tumors of the hand, with simple ganglion cysts being the most common. Chassaignac first described these benign soft-tissue masses in 1852, and he overstated their biologic potential in referring to them as cancers of the tendon sheath.
Giant cell tumors of the soft tissue are classified into the following two types:
The rare diffuse form is considered the soft-tissue counterpart of diffuse pigmented villonodular synovitis (PVNS) and typically affects the lower extremities. Its anatomic distribution parallels that of PVNS, with lesions most commonly found around the knee, followed by the ankle and foot; however, it occasionally affects the hand. Typically, these lesions, like those of PVNS, occur in young patients; 50% of cases are diagnosed in patients younger than 40 years. The diffuse form is often locally aggressive, and multiple recurrences after excision are common.
Because of the similarities in age, tumor locations, clinical presentations, and symptoms for patients with PVNS and patients with the diffuse form of giant cell tumors of the tendon sheath, the diffuse form probably represents an extra-articular extension of a primary intra-articular PVNS process.
Findings from flow cytometric DNA analysis suggest that PVNS and giant cell tumors of the tendon sheath are histopathologically similar but clinically distinct lesions.[3, 4, 4] When the origin of these poorly confined soft-tissue masses is uncertain, Enzinger and Weiss classify these tumors as the diffuse type of giant cell tumors of the tendon sheath, whether or not they involve the adjacent joint.
This article focuses on the common localized form of giant cell tumors—that is, the giant cell tumors of the tendon sheath that are often found in the hands and feet.[7, 8, 9, 10, 11]
As is true for most soft-tissue tumors, the etiology of giant cell tumors of the tendon sheath is unknown. Pathogenetic theories have included trauma, disturbed lipid metabolism, osteoclastic proliferation, infection, vascular disturbances, immune mechanisms, inflammation, neoplasia, and metabolic disturbances. Probably the most widely accepted theory, as Jaffe et al proposed, is that of a reactive or regenerative hyperplasia associated with an inflammatory process.
Histochemical evidence shows that the mononuclear cells and giant cells present in these lesions resemble osteoclasts,[14, 15] and this resemblance suggests a bone marrow–derived monocyte/macrophage lineage for these tumors. Polymerase chain reaction (PCR) assays have shown that giant cell tumors of the tendon sheath are polyclonal proliferations, which suggests that these masses are nonneoplastic proliferations, if one accepts the premise that a population of cells forming a tumorous mass must show clonality to be classified as a neoplasm.
Giant cell tumors of the tendon sheath are the second most common tumors in the hand; simple ganglion cysts are the most common. Giant cell tumors of the tendon sheath most commonly occur in patients aged 30-50 years, with a peak incidence in those aged 40-50 years. Rarely are these tumors found in patients younger than 10 years or older than 60 years. The female-to-male ratio is 3:2.
Giant cell tumors of the tendon sheath are associated with degenerative joint disease, especially in the distal interphalangeal (DIP) joint. Jones et al noted degenerative joint disease in the joint from which a tumor arose or in the joint nearest to the mass in 46 of 91 cases in which radiographs were reviewed.
An occasional association with rheumatoid arthritis has been reported; however, to the authors' knowledge, no pathogenetic relation between rheumatoid arthritis and giant cell tumor of the tendon sheath has been demonstrated, and their simultaneous occurrence may be coincidental. Antecedent trauma occurs in a variable number of these patients, but its association with these tumors is also probably coincidental.
The incidence of local recurrence is high, ranging from 9% to 44%. Researchers have reported the following rates:
Phalen et al,  9% recurrence rate in 56 cases
Moore et al,  9% recurrence rate in 115 cases
Jones et al,  17% recurrence rate in 95 cases
Reilly et al,  27% recurrence rate in 70 cases
Wright,  44% recurrence rate in 69 cases
The variability in rates probably reflects incomplete excision of the lesions, especially the satellite nodules. Risk factors for recurrence include the following:
Presence of adjacent degenerative joint disease
Injury at the DIP joint of the finger or the interphalangeal (IP) joint of the thumb
Radiographic presence of osseous pressure erosions
Goda et al have presented a new technique for the use of radiotherapy as an adjuvant modality to prevent local recurrence. For retrospective studies, see Rodrigues et al, Darwish and Haddad, and Messoudi et al. For a significant study in children, see Gholve et al.
To the authors' knowledge, no cases of malignant degeneration of a benign giant cell tumor of the tendon sheath of the hand have been reported. These tumors also have no propensity to metastasize distally. A few sporadic cases of purported malignant giant cell tumors have been reported; however, most authors doubt that these malignant tumors exist, because this diagnosis is difficult to confirm.
Di Grazia S, Succi G, Fragetta F, Perrotta RE. Giant cell tumor of tendon sheath: study of 64 cases and review of literature. G Chir. 2013 May-Jun. 34(5-6):149-52. [Medline]. [Full Text].
Murphey MD, Rhee JH, Lewis RB, Fanburg-Smith JC, Flemming DJ, Walker EA. Pigmented villonodular synovitis: radiologic-pathologic correlation. Radiographics. 2008 Sep-Oct. 28(5):1493-518. [Medline].
Abdul-Karim FW, el-Naggar AK, Joyce MJ. Diffuse and localized tenosynovial giant cell tumor and pigmented villonodular synovitis: a clinicopathologic and flow cytometric DNA analysis. Hum Pathol. 1992 Jul. 23(7):729-35. [Medline].
Mathews RE, Gould JS, Kashlan MB. Diffuse pigmented villonodular tenosynovitis of the ulnar bursa--a case report. J Hand Surg [Am]. 1981 Jan. 6(1):64-9. [Medline].
Enzinger FM, Weiss SH. Benign tumors and tumorlike lesions of synovial tissue. In: Enzinger FM, Weiss SW, eds. Soft Tissue Tumors. St Louis, Mo: Mosby. 1995:735-55.
Abimelec P, Cambiaghi S, Thioly D. Subungual giant cell tumor of the tendon sheath. Cutis. 1996 Oct. 58(4):273-5. [Medline].
Choudhury M, Jain R, Nangia A. Localized tenosynovial giant cell tumor of tendon sheath. A case report. Acta Cytol. 2000 May-Jun. 44(3):463-6. [Medline].
Ciattaglia G, Filosa G, Bugatti L. Giant cell tumor of tendon sheath. J Am Acad Dermatol. 1991 Oct. 25(4):728-9. [Medline].
LaRussa LR, Labs K, Schmidt RG. Giant cell tumor of tendon sheath. J Foot Ankle Surg. 1995 Nov-Dec. 34(6):541-6. [Medline].
Schleicher SM. Giant cell tumor of tendon sheath. Cutis. 1997 Mar. 59(3):133-4. [Medline].
Wu NL, Hsiao PF, Chen BF, et al. Malignant giant cell tumor of the tendon sheath. Int J Dermatol. 2004 Jan. 43(1):54-7. [Medline].
Hosaka M, Hatori M, Smith R, Kokubun S. Giant cell formation through fusion of cells derived from a human giant cell tumor of tendon sheath. J Orthop Sci. 2004. 9(6):581-4. [Medline].
Jaffe HL, Lichtenstein HL, Elsutro CJ. Pigmented villonodular synovitis, bursitis, and tenosynovitis. Arch Pathol. 1941. 31:731-65.
Darling JM, Goldring SR, Harada Y. Multinucleated cells in pigmented villonodular synovitis and giant cell tumor of tendon sheath express features of osteoclasts. Am J Pathol. 1997 Apr. 150(4):1383-93. [Medline].
Wood GS, Beckstead JH, Medeiros LJ. The cells of giant cell tumor of tendon sheath resemble osteoclasts. Am J Surg Pathol. 1988 Jun. 12(6):444-52. [Medline].
Vogrincic GS, O''Connell JX, Gilks CB. Giant cell tumor of tendon sheath is a polyclonal cellular proliferation. Hum Pathol. 1997 Jul. 28(7):815-9. [Medline].
Jones FE, Soule EH, Coventry MB. Fibrous xanthoma of synovium (giant-cell tumor of tendon sheath, pigmented nodular synovitis). A study of one hundred and eighteen cases. J Bone Joint Surg Am. 1969 Jan. 51(1):76-86. [Medline].
Reginato A, Martinez V, Schumacher HR. Giant cell tumour associated with rheumatoid arthritis. Ann Rheum Dis. 1974 Jul. 33(4):333-41. [Medline].
Phalen GS, McCormack LJ, Gazale WJ. Giant-cell tumor of tendon sheath (benign synovioma) in the hand. Evaluation of 56 cases. Clin Orthop. 1959. 15:140-51. [Medline].
Moore JR, Weiland AJ, Curtis RM. Localized nodular tenosynovitis: experience with 115 cases. J Hand Surg [Am]. 1984 May. 9(3):412-7. [Medline].
Reilly KE, Stern PJ, Dale JA. Recurrent giant cell tumors of the tendon sheath. J Hand Surg [Am]. 1999 Nov. 24(6):1298-302. [Medline].
Wright CJE. Benign giant-cell synovioma; an investigation of 85 cases. Br J Surg. 1951 Jan. 38(151):257-71. [Medline].
Goda JS, Patil P, Krishnappan C, Elangovan D. Giant cell tumor of the tendon sheath treated by brachytherapy (surface mold) technique-A technical illustration. Brachytherapy. 2008 Oct 22. [Medline].
Rodrigues C, Desai S, Chinoy R. Giant cell tumor of the tendon sheath: a retrospective study of 28 cases. J Surg Oncol. 1998 Jun. 68(2):100-3. [Medline].
Darwish FM, Haddad WH. Giant cell tumour of tendon sheath: experience with 52 cases. Singapore Med J. 2008 Nov. 49(11):879-82. [Medline].
Messoudi A, Fnini S, Labsaili N, Ghrib S, Rafai M, Largab A. [Giant cell tumors of the tendon sheath of the hand: 32 cases]. Chir Main. 2007 Jun. 26(3):165-9. [Medline].
Gholve PA, Hosalkar HS, Kreiger PA, Dormans JP. Giant cell tumor of tendon sheath: largest single series in children. J Pediatr Orthop. 2007 Jan-Feb. 27(1):67-74. [Medline].
Briët JP, Becker SJ, Oosterhoff TCh, Ring D. Giant cell tumor of tendon sheath. Arch Bone Jt Surg. 2015 Jan. 3 (1):19-21. [Medline].
Suresh SS, Zaki H. Giant cell tumor of tendon sheath: case series and review of literature. J Hand Microsurg. 2010 Dec. 2(2):67-71. [Medline]. [Full Text].
Garg B, Kotwal PP. Giant cell tumour of the tendon sheath of the hand. J Orthop Surg (Hong Kong). 2011 Aug. 19(2):218-20. [Medline].
Hamdi MF, Touati B, Zakhama A. Giant cell tumour of the flexor tendon sheath of the hand: analysis of 27 cases. Musculoskelet Surg. 2011 Jun 15. [Medline].
Findling J, Lascola NK, Groner TW. Giant cell tumor of the flexor hallucis longus tendon sheath: a case study. J Am Podiatr Med Assoc. 2011 Mar-Apr. 101(2):187-9. [Medline].
Stewart MJ. Benign giant-cell synovioma and its relation to "xanthoma". JBJS. 1948. 30B:522-7.
Jelinek JS, Kransdorf MJ, Shmookler BM. Giant cell tumor of the tendon sheath: MR findings in nine cases. AJR Am J Roentgenol. 1994 Apr. 162(4):919-22. [Medline].
Bancroft LW, Peterson JJ, Kransdorf MJ. Imaging of soft tissue lesions of the foot and ankle. Radiol Clin North Am. 2008 Nov. 46(6):1093-103. [Medline].
Wang Y, Tang J, Luo Y. The value of sonography in diagnosing giant cell tumors of the tendon sheath. J Ultrasound Med. 2007 Oct. 26(10):1333-40. [Medline].
Agarwal PK, Gupta M, Srivastava A. Cytomorphology of giant cell tumor of tendon sheath. A report of two cases. Acta Cytol. 1997 Mar-Apr. 41(2):587-9. [Medline].
Iyer VK, Kapila K, Verma K. Fine-needle aspiration cytology of giant cell tumor of tendon sheath. Diagn Cytopathol. 2003 Aug. 29(2):105-10. [Medline].